{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:41:08Z","timestamp":1782891668521,"version":"3.54.5"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11899-014-0218-1","type":"journal-article","created":{"date-parts":[[2014,9,20]],"date-time":"2014-09-20T03:32:53Z","timestamp":1411183973000},"page":"262-272","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical Aspects of Malt Lymphomas"],"prefix":"10.1007","volume":"9","author":[{"given":"Christina","family":"Kalpadakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos A.","family":"Pangalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodoros P.","family":"Vassilakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Kyriakaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xanthi","family":"Yiakoumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Sachanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Moschogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis","family":"Tsirkinidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope","family":"Korkolopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria K.","family":"Angelopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,21]]},"reference":[{"key":"218_CR1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/1097-0142(19831015)52:8<1410::AID-CNCR2820520813>3.0.CO;2-3","volume":"52","author":"PG Isaacson","year":"1983","unstructured":"Isaacson PG, Wright DH. Malignant lymphoma of mucosa associated lymphoid tissue. A distinct type of B-cell lymphoma. Cancer. 1983;52:1410\u20136.","journal-title":"Cancer"},{"key":"218_CR2","first-page":"214","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"PG Isaacson","year":"2008","unstructured":"Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC Press; 2008. p. 214\u20137.","edition":"4"},{"key":"218_CR3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1023\/A:1008282818705","volume":"8","author":"E Zucca","year":"1997","unstructured":"Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin\u2019s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8:727\u201337.","journal-title":"Ann Oncol"},{"key":"218_CR4","doi-asserted-by":"crossref","unstructured":"A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The non-Hodgkin\u2019s Lymphoma Classification Project. Blood 1997; 89: 3909-3918.","DOI":"10.1182\/blood.V89.11.3909"},{"issue":"119","key":"218_CR5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/cncr.27773","volume":"1","author":"AJ Olszewski","year":"2013","unstructured":"Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2013;1(119):629\u201338.","journal-title":"Cancer"},{"key":"218_CR6","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/cncr.11415","volume":"97","author":"S Nakamura","year":"2003","unstructured":"Nakamura S, Matsumoto T, Irida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462\u201373.","journal-title":"Cancer"},{"key":"218_CR7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","volume":"342","author":"A Wotherspoon","year":"1993","unstructured":"Wotherspoon A, Doglioni C, Diss T, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575\u20137.","journal-title":"Lancet"},{"key":"218_CR8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.semcancer.2013.09.004","volume":"23","author":"AJ Ferreri","year":"2013","unstructured":"Ferreri AJ, Govi S, Ponzoni M. Marginal zone lymphomas and infectious agents. Semin Cancer Biol. 2013;23:431\u201340.","journal-title":"Semin Cancer Biol"},{"key":"218_CR9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa031887","volume":"350","author":"M Lecuit","year":"2004","unstructured":"Lecuit M, Abachin E, Martin A, et al. Immunoproliferative small intestinal disease associated with Cambylobacter jejuni. N Engl J Med. 2004;350:239\u201348.","journal-title":"N Engl J Med"},{"key":"218_CR10","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337\u201344.","journal-title":"Arch Intern Med"},{"key":"218_CR11","first-page":"459","volume":"40","author":"K Aozasa","year":"1990","unstructured":"Aozasa K. Hashimoto\u2019s thyroiditis as a risk factor of thyroid lymphoma. Acta Pathol Jpn. 1990;40:459\u201368.","journal-title":"Acta Pathol Jpn"},{"key":"218_CR12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.beha.2004.08.003","volume":"18","author":"PG Isaacson","year":"2005","unstructured":"Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol. 2005;18:57\u201368.","journal-title":"Best Pract Res Clin Haematol"},{"key":"218_CR13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","volume":"338","author":"AC Wotherspoon","year":"1991","unstructured":"Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175\u20136.","journal-title":"Lancet"},{"key":"218_CR14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.semcancer.2013.11.005","volume":"24","author":"C Thieblemont","year":"2014","unstructured":"Thieblemont C, Bertoni F, Copie-Bergman C, Ferreri A, Ponzoni M. Chronic inflammation and extranodal marginal-zone lymphomas of MALT-type. Semin Cancer Biol. 2014;24:33\u201342. A detailed analysis of the current knowledge on the pathogenesis of MALT lymphoma, which shows the interplay between antigen activation and microenvironment.","journal-title":"Semin Cancer Biol"},{"key":"218_CR15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/jnci\/djh138","volume":"96","author":"E Jaffe","year":"2004","unstructured":"Jaffe E. Common threads of mucosa-associated lymphoid tissue lymphoma pathogenesis: from infection to translocation. J Natl Cancer Inst. 2004;96:571\u20133.","journal-title":"J Natl Cancer Inst"},{"key":"218_CR16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1182\/asheducation-2013.1.109","volume":"2013","author":"SH Kuo","year":"2013","unstructured":"Kuo SH, Cheng AL. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new. Hematol Am Soc Hematol Educ Program. 2013;2013:109\u201317.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"218_CR17","first-page":"1583","volume":"150","author":"A Greiner","year":"1997","unstructured":"Greiner A, Kn\u00f6rr CQY, Sebald W, Schimpl A, Banchereau J. M\u00fcller-HermelinkHK. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol. 1997;150:1583\u201393.","journal-title":"Am J Pathol"},{"key":"218_CR18","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/leu.2010.76","volume":"24","author":"V Craig","year":"2010","unstructured":"Craig V, Cogliatti SB, Gerke AI, Balandat C, W\u00fcndisch JE, M\u00fcller TA. B-cell receptor signaling and CD40 ligand-independent T cell help cooperate in Helicobacter-induced MALT lymphomagenesis. Leukemia. 2010;24:1186\u201396.","journal-title":"Leukemia"},{"key":"218_CR19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nrgastro.2010.58","volume":"7","author":"X Sagaert","year":"2010","unstructured":"Sagaert X, Van Cutsem E, De Hertogh G, Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastroenterol Hepatol. 2010;7:336\u201346.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"218_CR20","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1089\/ars.2011.4494","volume":"16","author":"E Bess\u00e8de","year":"2012","unstructured":"Bess\u00e8de E, Copie-Bergman LP, et al. Is elevated gastric tissue NOX2 associated with lymphoma of mucosa-associated lymphoid tissue? Antioxid Redox Signal. 2012;16:1205\u201311.","journal-title":"Antioxid Redox Signal"},{"key":"218_CR21","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2002-11-3502","volume":"102","author":"H Ye","year":"2003","unstructured":"Ye H, Liu H, Attygalle A, et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood. 2003;102:1012\u20138.","journal-title":"Blood"},{"key":"218_CR22","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1158\/0008-5472.CAN-09-4690","volume":"70","author":"WC Lin","year":"2010","unstructured":"Lin WC, Tsai HF, Kuo SH, et al. Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa associated lymphoid tissue lymphoma. Cancer Res. 2010;70:5740\u20138.","journal-title":"Cancer Res"},{"key":"218_CR23","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1182\/blood-2010-06-293266","volume":"117","author":"F Munari","year":"2011","unstructured":"Munari F, Lonardi SCM, Doglioni C, et al. Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood. 2011;117:6612\u20136.","journal-title":"Blood"},{"key":"218_CR24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1523-5378.2010.00801.x","volume":"15","author":"A Suzuki","year":"2010","unstructured":"Suzuki A, Kobayashi MMK, Matsumoto T, et al. Induction of high endothelial venule-like vessels expressing GlcNAc6ST-1-mediated L-selectin ligand carbohydrate and mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in a mouse model of \u201cCandidatus Helicobac-ter heilmannii\u201d-induced gastritis and gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Helicobacter. 2010;15:538\u201348.","journal-title":"Helicobacter"},{"key":"218_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/path.2851","volume":"224","author":"M Kobayashi","year":"2011","unstructured":"Kobayashi M, Mitoma JHH, Yu SY, et al. Prominent expression of sialyl Lewis X-capped core 2-branched O-glycans on high endothelial venule-like vessels in gastric MALT lymphoma. J Pathol. 2011;224:67\u201377.","journal-title":"J Pathol"},{"key":"218_CR26","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1172\/JCI7830","volume":"104","author":"L Mazzucchelli","year":"1999","unstructured":"Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest. 1999;104:R49\u201354.","journal-title":"J Clin Invest"},{"key":"218_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/1042819031000060546","volume":"44","author":"K Ohshima","year":"2003","unstructured":"Ohshima K, Suefuji H, Karube K, et al. Expression of chemokine receptor CXCR3 and its ligand, mig, in gastric and thyroid marginal zone lymphomas. Possible migration and autocrine mechanism. Leuk Lymphoma. 2003;44:329\u201336.","journal-title":"Leuk Lymphoma"},{"key":"218_CR28","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1349-7006.2008.00870.x","volume":"99","author":"H Yamamoto","year":"2008","unstructured":"Yamamoto H, Nakamura T, Matsuo K, et al. Significance of CXCR3 expression in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type for predicting responsiveness to Helicobacter pylori eradication. Cancer Sci. 2008;99:1769\u201373.","journal-title":"Cancer Sci"},{"key":"218_CR29","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/modpathol.2012.134","volume":"26","author":"AJ Deutsch","year":"2013","unstructured":"Deutsch AJ, Steinbauer E, Hofmann NA, et al. Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma. Mod Pathol. 2013;26:182\u201394.","journal-title":"Mod Pathol"},{"key":"218_CR30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/bcj.2012.1","volume":"2","author":"L Lisio Di","year":"2012","unstructured":"Di Lisio L, Sanchez-Beato M, Gomez-Lopez G, et al. MicroRNA signatures in B-cell lymphomas. Blood Cancer J. 2012;2:57.","journal-title":"Blood Cancer J"},{"key":"218_CR31","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/modpathol.2010.139","volume":"23","author":"TY Liu","year":"2010","unstructured":"Liu TY, Chen SU, Kuo SH, Cheng AL, Lin CW. E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment response. Mod Pathol. 2010;23:1507\u201317.","journal-title":"Mod Pathol"},{"key":"218_CR32","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1158\/0008-5472.CAN-10-3907","volume":"71","author":"VJ Craig","year":"2011","unstructured":"Craig VJ, Cogliatti SB, Rehrauer H, Wundisch T, Muller A. Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res. 2011;71:3616\u201324.","journal-title":"Cancer Res"},{"key":"218_CR33","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1080\/10428190701573224","volume":"48","author":"Q Huang","year":"2007","unstructured":"Huang Q, Su X, Ai L, Li M, Fan CY, Weiss LM. Promoter hypermethylation of multiple genes in gastric lymphoma. Leuk Lymphoma. 2007;48:1988\u201396.","journal-title":"Leuk Lymphoma"},{"key":"218_CR34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000195698","volume":"120","author":"S Park","year":"2008","unstructured":"Park S, Kim KM, Kim JJ, Lee JH, Rhee JC, Ko YH. Methylation of p16INK4A and mitotic arrest defective protein 2 (MAD2) genes in gastric marginal-zone B-cell lymphomas. Acta Haematol. 2008;120:217\u201324.","journal-title":"Acta Haematol"},{"key":"218_CR35","first-page":"547","volume":"35","author":"T Kondo","year":"2009","unstructured":"Kondo T, Oka T, Sato H, et al. Accumulation of aberrant CpG hypermethylation by Helicobacter pylori infection promotes development and progression of gastric MALT lymphoma. Int J Oncol. 2009;35:547\u201357.","journal-title":"Int J Oncol"},{"key":"218_CR36","first-page":"1190","volume":"10","author":"M Du","year":"1996","unstructured":"Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia. 1996;10:1190\u20137.","journal-title":"Leukemia"},{"key":"218_CR37","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1182\/blood.V86.9.3528.bloodjournal8693528","volume":"86","author":"Y Qin","year":"1995","unstructured":"Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Muller-Hermelink HK. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood. 1995;86:3528\u201334.","journal-title":"Blood"},{"key":"218_CR38","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1182\/blood.V89.9.3335","volume":"89","author":"DW Bahler","year":"1997","unstructured":"Bahler DW, Miklos JA, Swerdlow SH. Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas. Blood. 1997;89:3335\u201344.","journal-title":"Blood"},{"key":"218_CR39","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1182\/blood.V91.7.2381","volume":"91","author":"A Tierens","year":"1998","unstructured":"Tierens A, Delabie J, Pittaluga S, Driessen A, Dewolfpeeters C. Mutation analysis of the rearranged immunoglobulin heavy chain genes of marginal zone cell lymphomas indicates an origin from different marginal zone B lymphocyte subsets. Blood. 1998;91:2381\u20136.","journal-title":"Blood"},{"key":"218_CR40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.humpath.2010.11.022","volume":"42","author":"H Xia","year":"2011","unstructured":"Xia H, Nakayama T, Sakuma H, et al. Analysis of API2-MALT1 fusion, trisomies, and immunoglobulin VH genes in pulmonary mucosa-associated lymphoid tissue lymphoma. Hum Pathol. 2011;42:1297\u2013304.","journal-title":"Hum Pathol"},{"key":"218_CR41","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1046\/j.1365-2141.1997.1392954.x","volume":"97","author":"F Bertoni","year":"1997","unstructured":"Bertoni F, Cazzaniga G, Bosshard G, et al. Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. Br J Haematol. 1997;97:830\u20136.","journal-title":"Br J Haematol"},{"key":"218_CR42","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1182\/blood-2009-06-228015","volume":"115","author":"V Craig","year":"2010","unstructured":"Craig V, Arnold I, Gerke C, et al. Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins. Blood. 2010;115:581\u201391.","journal-title":"Blood"},{"key":"218_CR43","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1182\/blood.V95.12.3878","volume":"95","author":"JA Miklos","year":"2000","unstructured":"Miklos JA, Swerdlow SH, Bahler DW. Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V (H) genes show frequent use of V1-69 with distinctive CDR3 features. Blood. 2000;95:3878\u201384.","journal-title":"Blood"},{"key":"218_CR44","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/leu.2011.276","volume":"26","author":"A Dagklis","year":"2012","unstructured":"Dagklis A, Ponzoni M, Govi S, et al. Immunoglobulin gene repertoire in ocular adnexal lymphomas: hints on the nature of the antigenic stimulation. Leukemia. 2012;26:814\u201321.","journal-title":"Leukemia"},{"key":"218_CR45","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/leu.2012.28","volume":"26","author":"F Maldegem van","year":"2012","unstructured":"van Maldegem F, Wormhoudt TA, Mulder MM, et al. Chlamydia psittaci-negative ocular adnexal marginal zone B-cell lymphomas have biased VH4-34 immunoglobulin gene expression and proliferate in a distinct inflammatory environment. Leukemia. 2012;26:1647\u201353.","journal-title":"Leukemia"},{"key":"218_CR46","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/modpathol.2009.42","volume":"22","author":"DW Bahler","year":"2009","unstructured":"Bahler DW, Szankasi P, Kulkarni S, Tubbs RR, Cook JR, Swerdlow SH. Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa. Mod Pathol. 2009;22:833\u20138.","journal-title":"Mod Pathol"},{"key":"218_CR47","doi-asserted-by":"crossref","first-page":"e29114","DOI":"10.1371\/journal.pone.0029114","volume":"6","author":"D Zhu","year":"2011","unstructured":"Zhu D, Lossos C, Chapman-Fredricks JR, et al. Biased use of the IGHV4 family and evidence for antigen selection in Chlamydophila psittaci-negative ocular adnexal extranodal marginal zone lymphomas. PLoS One. 2011;6:e29114.","journal-title":"PLoS One"},{"key":"218_CR48","doi-asserted-by":"crossref","unstructured":"Owens SR, Smith LB. Molecular aspects of H. pylori-related MALT Lymphoma. Patholog Res Int 2011;193149 [PMID:21318155].","DOI":"10.4061\/2011\/193149"},{"key":"218_CR49","first-page":"1134","volume":"25","author":"F Bertoni","year":"2011","unstructured":"Bertoni F, Coiffier B, Salles G, et al. MALT lymphomas: pathogenesis can drive treatment. Oncology. 2011;25:1134\u201342.","journal-title":"Oncology"},{"key":"218_CR50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2141.2008.07284.x","volume":"143","author":"G Packham","year":"2008","unstructured":"Packham G. The role of NF-kappaB in lymphoid malignancies. Br J Haematol. 2008;143:3\u201315.","journal-title":"Br J Haematol"},{"key":"218_CR51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2559.2010.03699.x","volume":"58","author":"MQ Du","year":"2011","unstructured":"Du MQ. MALT lymphoma: many roads lead to nuclear factor-b activation. Histopathology. 2011;58:26\u201338.","journal-title":"Histopathology"},{"key":"218_CR52","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1182\/blood.V95.12.4014","volume":"95","author":"B Alpen","year":"2000","unstructured":"Alpen B, Neubauer A, Dierlamm J, et al. Translocation t(11;18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood. 2000;95:4014\u20135.","journal-title":"Blood"},{"key":"218_CR53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(00)03571-6","volume":"357","author":"H Liu","year":"2001","unstructured":"Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A, et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 2001;357:39\u201340.","journal-title":"Lancet"},{"key":"218_CR54","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1172\/JCI27476","volume":"116","author":"F Bertoni","year":"2006","unstructured":"Bertoni F, Zucca E. Delving deeper into MALT lymphoma biology. J Clin Invest. 2006;116:22\u20136.","journal-title":"J Clin Invest"},{"key":"218_CR55","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","volume":"18","author":"B Streubel","year":"2004","unstructured":"Streubel B, Simonitsch-Klupp I, Mullauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia. 2004;18:1722\u20136.","journal-title":"Leukemia"},{"key":"218_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gcc.20499","volume":"47","author":"K Honma","year":"2008","unstructured":"Honma K, Tsuzuki S, Nakagawa M, et al. TNFAIP3 is the target gene of chromosome band 6q23.3\u2013q24.1 loss in ocular adnexal marginal zone B cell lymphoma. Genes Chromosome Cancer. 2008;47:1\u20137.","journal-title":"Genes Chromosome Cancer"},{"key":"218_CR57","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3324\/haematol.2011.040402","volume":"96","author":"I Kwee","year":"2011","unstructured":"Kwee I, Rancoita PM, Rinaldi A, et al. Genomic profiles of MALT lymphomas: variability across anatomic sites. Haematologica. 2011;96:1064\u20136.","journal-title":"Haematologica"},{"key":"218_CR58","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2559.1987.tb02654.x","volume":"11","author":"PG Isaacson","year":"1987","unstructured":"Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 1987;11:445\u201362.","journal-title":"Histopathology"},{"key":"218_CR59","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/leu.2009.108","volume":"23","author":"G Kanellis","year":"2009","unstructured":"Kanellis G, Roncador G, Arribas A, et al. Identification of MNDA as a new marker for nodal marginal zone lymphoma. Leukemia. 2009;23:1847\u201357.","journal-title":"Leukemia"},{"key":"218_CR60","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1365-2559.2012.04289.x","volume":"61","author":"B Falini","year":"2012","unstructured":"Falini B, Agostinelli C, Bigerna B, et al. IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas. Histopathology. 2012;61:930\u201341.","journal-title":"Histopathology"},{"key":"218_CR61","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1182\/blood.V87.4.1255.bloodjournal8741255","volume":"87","author":"A Savio","year":"1996","unstructured":"Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood. 1996;87:1255\u201360.","journal-title":"Blood"},{"key":"218_CR62","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2002-04-1279","volume":"101","author":"E Zucca","year":"2003","unstructured":"Zucca E, Conconi A, Pedrinis E, et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood. 2003;101:2489\u201395.","journal-title":"Blood"},{"key":"218_CR63","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.1997.15.4.1624","volume":"15","author":"C Thieblemont","year":"1997","unstructured":"Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and non gastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997;15:1624\u201330.","journal-title":"J Clin Oncol"},{"key":"218_CR64","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1200\/JCO.2006.06.0723","volume":"24","author":"M Raderer","year":"2006","unstructured":"Raderer M, Wohrer S, Streubel B, et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single center experience. J Clin Oncol. 2006;24:3136\u201341.","journal-title":"J Clin Oncol"},{"key":"218_CR65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.11835","volume":"93","author":"JP Boer de","year":"2008","unstructured":"de Boer JP, Hiddink RF, Raderer M, et al. Dissemination patterns in non-gastric MALT lymphoma. Haematologica. 2008;93:201\u20136.","journal-title":"Haematologica"},{"key":"218_CR66","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1080\/10428190802510331","volume":"49","author":"C Kalpadakis","year":"2008","unstructured":"Kalpadakis C, Pangalis GA, Vassilakopoulos TP, et al. Non-gastric MALT lymphomas a single center experience on 76 patients. Leuk Lymphoma. 2008;49:2308\u201315.","journal-title":"Leuk Lymphoma"},{"key":"218_CR67","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.V95.3.802.003k19_802_806","volume":"95","author":"C Thieblemont","year":"2000","unstructured":"Thieblemont C, Berger F, Dumonter C, et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood. 2000;95:802\u20136.","journal-title":"Blood"},{"key":"218_CR68","first-page":"635","volume":"30","author":"M Troch","year":"2010","unstructured":"Troch M, W\u00f6hrer S, Raderer M. Assessment of the prognostic indices IPI and FLIPI in patients with mucosa-associated lymphoid tissue lymphoma. Anticancer Res. 2010;30:635\u20139.","journal-title":"Anticancer Res"},{"key":"218_CR69","doi-asserted-by":"crossref","first-page":"vi144","DOI":"10.1093\/annonc\/mdt343","volume":"24","author":"E Zucca","year":"2013","unstructured":"Zucca E, Copie-Bergman C, Ricardi C, Thieblemont C, Raderer M, Ladetto M. Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practise Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi144\u20138. Practical guidelines for the management of gastric MALT lymphomas by ESMO.","journal-title":"Ann Oncol"},{"key":"218_CR70","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1136\/gut.52.6.912","volume":"52","author":"A Ruskone-Fourmestraux","year":"2003","unstructured":"Ruskone-Fourmestraux A, Dragosics B, Morgner A, et al. Paris staging system for primary gastrointestinal lymphomas. Gut. 2003;52:912\u20133.","journal-title":"Gut"},{"key":"218_CR71","doi-asserted-by":"crossref","first-page":"a1454","DOI":"10.1136\/bmj.a1454","volume":"337","author":"L Fuccio","year":"2008","unstructured":"Fuccio L, Laterza L, Zagari RM, et al. Treatment of Helicobacter pylori infection. Brit Med J. 2008;337:a1454.","journal-title":"Brit Med J"},{"key":"218_CR72","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1038\/ajg.2009.314","volume":"104","author":"A Zullo","year":"2009","unstructured":"Zullo A, Hassan C, Andriani A, et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol. 2009;104:1932\u20137.","journal-title":"Am J Gastroenterol"},{"key":"218_CR73","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cgh.2009.07.017","volume":"8","author":"A Zullo","year":"2010","unstructured":"Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010;8:105\u201310. This article presents the results of antihelicobacter therapy on a large number of patients with gastric MALT lymphoma, as well as the outcome after a long follow-up time.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"218_CR74","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/gut.2005.083022","volume":"55","author":"M Raderer","year":"2006","unstructured":"Raderer M, Streubel B, Wohrer S, Hafner M, Chott. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa-associated lymphoid tissue lymphomas. Gut. 2006;55:616\u20138.","journal-title":"Gut"},{"key":"218_CR75","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/hel.12051","volume":"18","author":"Y Iwaya","year":"2013","unstructured":"Iwaya Y, Kobayashi M, Momose M, et al. High levels of FOXP3+ regulatory T cells in gastric MALT lymphoma predict responsiveness to Helicobacter pylori eradication. Helicobacter. 2013;18:356\u201362. This study confirms the important role of T-cells, and particularly T-regs, in MALT lymphomatogenesis, as well as the impact of T-regs in the response to antihelicobacter therapy.","journal-title":"Helicobacter"},{"key":"218_CR76","doi-asserted-by":"crossref","first-page":"e47396","DOI":"10.1371\/journal.pone.0047396","volume":"7","author":"Y Saito","year":"2012","unstructured":"Saito Y, Suzuki H, Tsugawa H, et al. Overexpression of miR-142-5p and miR-155 in Gastric Mucosa-Associated Lymphoid Tissue (MALT) lymphoma resistant to Helicobacter pylori eradication. PLoS ONE. 2012;7:e47396.","journal-title":"PLoS ONE"},{"key":"218_CR77","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1634\/theoncologist.2008-0178","volume":"14","author":"MP Siakantaris","year":"2009","unstructured":"Siakantaris MP, Pangalis GA, Dimitriadou E, et al. Early stage gastric MALT lymphoma. Is it a true localized disease? Oncologist. 2009;14:148\u201354.","journal-title":"Oncologist"},{"key":"218_CR78","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","volume":"52","author":"C Copie-Bergman","year":"2003","unstructured":"Copie-Bergman C, Gaulard P, Lavergne-Slove A, et al. Proposals for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma. Gut. 2003;52:1656.","journal-title":"Gut"},{"key":"218_CR79","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3748\/wjg.v7.i2.248","volume":"7","author":"A Morgner","year":"2001","unstructured":"Morgner A, Miehlke S, Stolte M, et al. Development of early gastric cancer 4 and 5\u00a0years after complete remission of Helicobacter pylori associated gastric low grade marginal zone B cell lymphoma of MALT type. World J Gastroenterol. 2001;7:248\u201353.","journal-title":"World J Gastroenterol"},{"issue":"Suppl 3","key":"218_CR80","first-page":"19","volume":"50","author":"M Stolte","year":"2002","unstructured":"Stolte M, Bayerdorffer E, Morgner A, et al. Helicobacter and MALT lymphoma. Gut. 2002;50 Suppl 3:19\u201324.","journal-title":"Gut"},{"key":"218_CR81","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/annonc\/mds623","volume":"24","author":"A Wirth","year":"2013","unstructured":"Wirth A, Gospodarowicz M, Aleman MB, et al. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multicenter, International Extranodal Lymphoma Study Group study. Ann Oncol. 2013;24:1344\u201351.","journal-title":"Ann Oncol"},{"key":"218_CR82","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijrobp.2013.11.225","volume":"88","author":"AJ Olszewski","year":"2014","unstructured":"Olszewski AJ, Desai A. Radiation therapy administration and survival in stage I\/II extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Int J Radiat Oncol Biol Phys. 2014;88:642\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"218_CR83","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-0609.2006.00720.x","volume":"77","author":"MC Kyrtsonis","year":"2006","unstructured":"Kyrtsonis MC, Siakandaris MP, Kalpadakis C, et al. Favorable outcome of primary cutaneous marginal zone lymphoma, treated with intralesional rituximab. Eur J Haematol. 2006;77:300\u20133.","journal-title":"Eur J Haematol"},{"key":"218_CR84","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1200\/JCO.2005.05.660","volume":"23","author":"M Levy","year":"2005","unstructured":"Levy M, Copie-Bergman C, Gameiro C, et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol. 2005;23:5061\u20136.","journal-title":"J Clin Oncol"},{"key":"218_CR85","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1200\/JCO.2002.05.117","volume":"20","author":"G Jager","year":"2002","unstructured":"Jager G, Neumeister P, Brezinschek R, et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol. 2002;20:3872\u20137.","journal-title":"J Clin Oncol"},{"key":"218_CR86","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/annonc\/mdg492","volume":"14","author":"S W\u00f6hrer","year":"2003","unstructured":"W\u00f6hrer S, Drach J. Hejna M, et al Treatment of extranodal marginal zone B-cell lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP). Ann Oncol. 2003;14:1758\u201361.","journal-title":"Ann Oncol"},{"key":"218_CR87","doi-asserted-by":"crossref","unstructured":"Zinzani PL, Stefoni V, Musuraca G, et al Fludarabine-containing chemotherapy as frontline treatment of Cancer 2004 15; 100: 2190-2194.","DOI":"10.1002\/cncr.20237"},{"key":"218_CR88","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1200\/JCO.2005.08.128","volume":"23","author":"G Martinelli","year":"2005","unstructured":"Martinelli G, Laszlo D, Ferrreri AJ, et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin\u2019s lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol. 2005;23:1979\u201383.","journal-title":"J Clin Oncol"},{"key":"218_CR89","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10428194.2012.729832","volume":"54","author":"M Levy","year":"2013","unstructured":"Levy M, Copie-Bergman C, Amiot A, et al. Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study. Leuk Lymphoma. 2013;54:940\u20134.","journal-title":"Leuk Lymphoma"},{"key":"218_CR90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1200\/JCO.2011.40.6272","volume":"31","author":"E Zucca","year":"2013","unstructured":"Zucca E, Conconi A, Laszlo D, et al. Addition of rituximab to chlorambucil produces superior event-free survival in the treatment of patient with extranodal marginal zone B-cell lymphoma: 5-year analysis of the IELSG-19 randomized study. J Clin Oncol. 2013;31:565\u201372. This is the first randomized study conducted by the IELSG in a large series of MALT lymphoma patients with long follow-up addressing the role of the addition of rituximab to chlorambucil.","journal-title":"J Clin Oncol"},{"key":"218_CR91","doi-asserted-by":"crossref","unstructured":"Thieblemont C. Clinical presentation and management of marginal zone lymphomas. Hematology Am Soc Hematol Educ Program. 2005:307-313.","DOI":"10.1182\/asheducation-2005.1.307"},{"key":"218_CR92","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1200\/JCO.2011.41.4466","volume":"30","author":"AJ Ferreri","year":"2012","unstructured":"Ferreri AJ, Govi S, Pasini E, et al. Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial. J Clin Oncol. 2012;30:2988\u201394.","journal-title":"J Clin Oncol"},{"key":"218_CR93","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1182\/blood-2013-02-486522","volume":"122","author":"B Kiesewetter","year":"2013","unstructured":"Kiesewetter B, Raderer M. Antibiotic therapy in nongastrointestinal MALT lymphoma: a review of the literature. Blood. 2013;122:1350\u20137.","journal-title":"Blood"},{"key":"218_CR94","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00277-013-1865-3","volume":"93","author":"B Kiesewetter","year":"2014","unstructured":"Kiesewetter B, Mayerhoefer ME, Lukas J, Zielinski CC, M\u00fcllauer L, Raderer M. Rituximab plus bendamustine is active in pretreated patients with extragastric marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma). Ann Hematol. 2014;93:249\u201353.","journal-title":"Ann Hematol"},{"key":"218_CR95","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3324\/haematol.2012.065995","volume":"98","author":"B Kiesewetter","year":"2013","unstructured":"Kiesewetter B, Troch M, Dolak W, et al. A phase II study of lenalidomide in patients with extranodal marginal zone B-cell lymphoma of the mucosa associated lymphoid tissue (MALT lymphoma). Haematologica. 2013;98:353\u20136.","journal-title":"Haematologica"},{"issue":"120","key":"218_CR96","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cncr.28405","volume":"15","author":"T Ahmadi","year":"2014","unstructured":"Ahmadi T, Chong EA, Gordon A, et al. Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas. Cancer. 2014;15(120):222\u20138.","journal-title":"Cancer"},{"key":"218_CR97","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1586\/eci.11.15","volume":"7","author":"C Bello","year":"2011","unstructured":"Bello C, Veliz M, Pinilla-Ibarz J. Ofatumumab in the treatment of low-grade non-Hodgkin's lymphomas and chronic lymphocytic leukemia. Expert Rev Clin Immunol. 2011;7:295\u2013300.","journal-title":"Expert Rev Clin Immunol"},{"issue":"23","key":"218_CR98","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1200\/JCO.2012.46.9718","volume":"31","author":"GA Salles","year":"2013","unstructured":"Salles GA, Morschhauser F, Solal-C\u00e9ligny P, et al. Obinutuzumab (GA101) in patients with relapsed\/refractory indolent non-Hodgkin lymphoma: results from the phase II GAUGUIN study. J Clin Oncol. 2013;31(23):2920\u20136.","journal-title":"J Clin Oncol"},{"issue":"31","key":"218_CR99","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1200\/JCO.2012.42.7906","volume":"1","author":"RH Advani","year":"2013","unstructured":"Advani RH, Buggy JJ, Sharman JP, et al. Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed\/refractory B-cell malignancies. J Clin Oncol. 2013;1(31):88\u201394.","journal-title":"J Clin Oncol"},{"key":"218_CR100","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/2040620712453595","volume":"3","author":"M Joshi","year":"2012","unstructured":"Joshi M, Sheikh H, Abbi K, et al. Marginal zone lymphoma: old, new, targeted, and epigenetic therapies. Ther Adv Hematol. 2012;3:275\u201390.","journal-title":"Ther Adv Hematol"},{"key":"218_CR101","author":"A Conconi","year":"2014","unstructured":"Conconi A, Raderer M, Franceschetti S, et al. Clinical activity of everolimus in relapsed\/refractory marginal zone B-cell lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group. Br J Haematol. 2014. doi: 10.1111\/bjh.12845 .","journal-title":"Br J Haematol"},{"key":"218_CR102","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdq416","volume":"22","author":"A Conconi","year":"2011","unstructured":"Conconi A, Martinelli G, Lopez-Guillermo A. et al; International Extranodal Lymphoma Study Group (IELSG). Clinical activity of bortezomib in relapsed\/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG). Ann Oncol. 2011;22:689\u201395.","journal-title":"Ann Oncol"}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-014-0218-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11899-014-0218-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-014-0218-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T18:36:44Z","timestamp":1598294204000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11899-014-0218-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["218"],"URL":"https:\/\/doi.org\/10.1007\/s11899-014-0218-1","relation":{},"ISSN":["1558-8211","1558-822X"],"issn-type":[{"value":"1558-8211","type":"print"},{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}